Obesity Intervention Devices Market - Global Obesity Intervention Devices Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Product Coverage, By End User Coverage, By Geographic Coverage and Leading Companies)

Obesity Intervention Devices Market - Global Obesity Intervention Devices Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Product Coverage, By End User Coverage, By Geographic Coverage and Leading Companies)

Global Obesity Intervention Devices Market Poised to Reach Nearly $0.5 Billion by 2030

The global obesity intervention devices market is on an upward trajectory, with a forecasted valuation of close to $0.5 billion by the year 2030, according to a recent market analysis. The report reveals a robust Compound Annual Growth Rate (CAGR) of 6% expected between 2023 and 2030.

Combatting the Obesity Epidemic

Obesity is a growing global concern, with the prevalence of obesity-related health issues on the rise. Conditions such as cardiovascular disease, type 2 diabetes, and musculoskeletal problems are becoming alarmingly common. This has spurred the demand for effective interventions to address and manage obesity, giving rise to the obesity intervention devices market.

Key Findings

The report highlights several key findings:

1. Rising Obesity Rates Worldwide: The global prevalence of obesity is increasing, with projections indicating that by 2030, one billion people worldwide will grapple with obesity. This underscores the need for innovative solutions to combat this public health crisis.

2. Reducing Healthcare Costs: Obesity-related conditions often lead to costly medical interventions, hospitalizations, and ongoing medication. Obesity intervention devices have the potential to reduce these costs by preventing or managing chronic diseases associated with obesity.

3. Preference for Space-occupying Devices: Gastric balloons, which create a sense of fullness in the stomach, are in high demand. They offer a non-surgical approach to weight loss, making them appealing to individuals hesitant about surgery.

4. Hospitals and Clinics Lead Adoption: Hospitals play a pivotal role in adopting and utilizing obesity intervention devices due to their advanced medical facilities, multidisciplinary approach to obesity management, and specialized healthcare professionals.

5. North America Dominates: North America, particularly the United States, leads the market, driven by a long-standing obesity epidemic, advanced healthcare infrastructure, and regulatory frameworks that encourage innovation.

6. Asia Pacific Presents Growth Potential: Asia Pacific is emerging as a lucrative market due to rapid urbanization, changing lifestyles, and increased awareness of obesity-related health risks.

Market Players

Leading companies in the obesity intervention devices market include Medtronic plc, ReShape Lifesciences, Inc., Cousin Surgery, BAROnova, Inc., A.M.I. GmbH, Johnson & Johnson, Spatz FGIA, Inc., Allurion Technologies, Inc., Endalis Laboratoire, GI Dynamics, Inc., Boston Scientific, and Abbvie, Inc.

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.